News
Gilead takes another big swing at expanding beyond HIV
21+ hour, 34+ min ago (58+ words) endpoints. news Gilead takes an'oth'er big swing at ex'pand'ing be'yond HIV Gilead Sci'ences has ded'i'cat'ed around $11 bil'lion so far this year to three ac'qui'si'tions meant to bol'ster its pipelines in can'cer and im'munol'o'gy. The phar'ma " Think we're worth reading - tell…...
Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
21+ hour, 20+ min ago (46+ words) endpoints. news Plus, news about No'vavax, Re'Al'ta and Atai Beck'ley: Mer'ck ad'justs Chi'na vac'cine sup'ply deal: The com'pa'ny and its dis'tri'b'u'tion part'ner Zhifei have tweaked their agree'ment as " Confirm Endpoints as a trusted biopharma news source...
Inside the Talkspace-Universal Health Services deal
22+ hour, 21+ min ago (231+ words) This March, Universal Health Services, an operator of hospitals and mental healthcare facilities, agreed to buy Talkspace for a total value of $835 million. The deal was a discount to the $1. 4 billion valuation Talkspace went public at in 2021. An SEC'document filed…...
ADC biotech Sidewinder collects $137 M for bispecific approach
1+ day, 1+ hour ago (57+ words) endpoints. news ADC biotech Sidewinder col'lects $137 M for bis'pe'cif'ic ap'proach A San Diego biotech look'ing to dou'ble up on the pow'er of an'ti'body-drug con'ju'gates with few'er tox'i'c'i'ties has patched to'geth'er a $137 mil'lion Se'ries B " Think we're worth reading - tell Google....
David Sinclair startup raises $80 M for clinical test of anti-aging gene therapy
1+ day, 44+ min ago (64+ words) David Sinclair startup Life Biosciences raises $80 M for clinical test of anti-aging gene therapy'endpoints. news David Sin'clair start'up rais'es $80 M for clin'i'cal test of an'ti-ag'ing gene ther'a'py A start'up de'vel'op'ing a one-time treat'ment that could rewind the clock on dy'ing…...
Insmed shelves Brinsupri in skin disease after mid-stage flop
1+ day, 2+ hour ago (61+ words) Endpoints News In'smed shelves Brin'supri in skin dis'ease af'ter mid-stage flop In'smed has giv'en up on Brin'supri in the painful skin dis'or'der hidradeni'tis sup'pu'ra'ti'va (HS) af'ter a mid-stage tri'al fail'ure. The com'pa'ny had ditched the pill " Think we're worth reading…...
European VC Jeito gets $1. 2 B to help private biotechs control their 'destiny"
1+ day, 5+ hour ago (66+ words) European VC Jeito gets $1. 2 B to help private biotechs control their "destiny'Endpoints News Eu'ro'pean VC Jeito gets $1. 2 B to help pri'vate biotechs con'trol their 'des'tiny' A dozen or so Eu'ro'pean drug de'vel'op'ment star'tups might soon get a ma'jor lift from…...
What's familiar in health tech's Q1 funding totals
1+ day, 17+ hour ago (61+ words) Endpoints News What's fa'mil'iar in health tech's Q1 fund'ing to'tals Health tech kicked off the year with a se'ries of eye-pop'ping fund'ing rounds. Whoop raised a $575 mil'lion Se'ries G last week. Oth'ers, like Open Ev'i'dence " Think we're worth reading - tell Google....
Study suggests $35 monthly insulin cap has increased patient access
1+ day, 17+ hour ago (60+ words) Endpoints News Study sug'gests $35 month'ly in'sulin cap has in'creased pa'tient ac'cess Di'a'betes pa'tients in Medicare spent sig'nif'i'cant'ly less on in'sulin in the first year af'ter a $35 month'ly cap was put in place in 2023 " and " Think we're worth reading - tell Google....
White House adds Abb Vie's Humira to Trump Rx alongside cheaper biosimilars
1+ day, 18+ hour ago (64+ words) Endpoints News White House adds Ab'b'Vie's Hu'mi'ra to Trump Rx along'side cheap'er biosim'i'lars The White House this week be'gan of'fer'ing a $950-per-month ver'sion of Ab'b'Vie's megablock'buster Hu'mi'ra on Trump Rx, even as the drug dis'count web'site al'so of'fers two " Think…...